Historically, only one-third of lymphoma patients receiving anthracyclines underwent guideline-recommended cardiac surveillance, and those developing cardiomyopathy had significantly higher mortality.
No takes yet. Share an insight, caveat, or question.
Low surveillance adherence may miss AC-CMP cases linked to higher mortality; hypothesis-generating for prospective monitoring trials.
Hung et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: